Research is exploring the relationship between circadian biomarkers and the regulation of therapeutic protein release. Studies are investigating various aspects of this connection, including its potential impact on different bodily systems and pathologies. The findings may have implications for understanding and treating a range of conditions, possibly including metabolic syndrome, cardiovascular metabolism, and intervertebral disc degeneration.